99 results on '"Pignatelli, P."'
Search Results
2. Low-grade endotoxemia, oxidative stress and thrombotic events in patients with primary antiphospholipid syndrome
3. Risk of major cardiovascular events and bleeding in atrial fibrillation patients with chronic obstructive pulmonary disease treated with low dose azithromycin prophylaxis
4. Short versus long-term anticoagulation for left ventricular thrombosis resolution during vitamin k antagonist therapy
5. Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry
6. Statin use is associated with a lower risk of mortality in patients with malignant breast cancer treated with anthracyclines. A global federated health database analysis
7. OC 29.1 Long-Term Outcomes of COVID-19 Associated Venous Thromboembolism (VTE)
8. PB0026 Low Platelet Count has a Strong Worsening Impact on Outcome in Patients with Acute Coronary Syndromes: From the START Antiplatelet Registry
9. OC 76.2 PAD4-mediated NETosis in ChAdOx1 Vaccine-Induced Thrombosis
10. OC 10.4 Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Nets Release Driver Thrombosis in Familial Hypercholesterolemia
11. Oral microbiota in patients with FH and very-high CV risk: What link?
12. Relationship between proprotein convertase subtilisin/kexin type 9 (PCSK9) and thrombotic events in primary antiphospholipid syndrome. The multicenter ATHERO-APS study
13. Bleeding and thrombotic events in patients with atrial fibrillation and cancer: a systematic review and meta-regression analysis
14. EP14.02-001 Could the Oxidative Stress Be Used as a Marker for Neuroendocrine Lung Tumors?
15. Higher oral porphyromonas gingivalis abundance is associated with the presence of atherosclerotic cardiovascular disease in high-risk patients and in patients with Heterozygous Familial Hypercholesterolemia
16. Prevalence of heart failure with preserved ejection fraction in antiphospholipid antibodies syndrome. The multicenter ATHERO-APS study
17. Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry
18. The Atrial fibrillation Better Care (ABC) pathway is associated to a lower incidence of cardiac complications in patients with atrial fibrillation: a report from the ATHERO-AF study
19. Risk of cardiovascular events in patients with atrial fibrillation and cancer. Data from the ATHERO-AF cohort
20. Effect of body mass index on ischemic and bleeding events in patients presenting with acute coronary syndromes: insights from the START-ANTIPLATELET registry
21. Clinical outcome with NOACs vs VKAs in patients with atrial fibrillation and severe chronic kidney disease: results of a retrospective, multicenter, real-world study
22. Ischemic and bleeding risk stratification in diabetic patients after acute coronary syndrome based on insulin requirement
23. Clinical phenotypes of atrial fibrillation and risk of mortality: a cluster analysis
24. Ticagrelor versus Clopidogrel in high bleeding risk patients presenting with Acute Coronary Syndromes: insights from the multicenter START-ANTIPLATELET registry
25. P5454PCSK9 as a predictor of cardiovascular events in atrial fibrillation: role of platelet activation
26. P3472Modifications of renal function in atrial fibrillation patients treated with different oral anticoagulants: a multicentre cohort study
27. Baseline data on the bionomics of Aedes aegypti to support dengue control strategies in Burkina Faso
28. Assessment of blood hydrogen peroxide break-down activity (HBA) in healthy subjects and in patients with atrial fibrillation: relation to cardiovascular events
29. Mechanisms of digoxin-related platelet activation in atrial fibrillation patients: In vivo and in vitro study
30. P312digoxin and platelet activation in atrial fibrillation patients
31. Aging and Adherence to the Mediterranean Diet: Relationship with Cardiometabolic Disorders and Polypharmacy
32. The Anopheles gambiae ATP‐binding cassette transporter family: phylogenetic analysis and tissue localization provide clues on function and role in insecticide resistance
33. P2641Circulating lipopolysaccharides and risk of major adverse cardiovascular events in atrial fibrillation: association with mediterranean diet adherence
34. P1733Proprotein convertase subtilisin/kexin type 9 (PCSK9), platelet activation and risk of cardiovascular events in atrial fibrillation
35. Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study
36. Short-termin vivomodifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F2αin HIV-1 patients on abacavir-based therapies
37. Enhanced Soluble Serum CD40L and Serum P-Selectin Levels in Primary Aldosteronism
38. Reply to “The relation between flow mediated dilation and atrial fibrillation” by S. Balta
39. Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjects
40. Respiratory Disease and the Incidence of Pulmonary Mycoplasmosis in Intensively-Reared Calves in Italy
41. Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants
42. Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis
43. P825 NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH REDUCED SERUM CHOLESTEROL-ADJUSTED VITAMIN E LEVELS
44. Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver
45. Epicatechin and Catechin Modulate Endothelial Activation Induced by Platelets of Patients with Peripheral Artery Disease
46. Vitamin e serum level, a new tool to stratify bleeding risk in patients receiving oral anticoagulant therapy
47. 598 IN VITRO EFFECT OF n-6/n-3 POLYUNSATURATED FATTY ACIDS ON PLATELET NOX2-MEDIATED OXIDATIVE STRESS IN LIVER CIRRHOSIS
48. 589 OXIDATIVE STRESS AND INFLAMMATION IN LIVER CIRRHOSIS: ROLE OF N-6/N-3 POLYUNSATURATED FATTY ACIDS BALANCE
49. Dark chocolate inhibits platelet isoprostanes via NOX2 down‐regulation in smokers
50. NOX2-mediated arterial dysfunction in smokers: acute effect of dark chocolate
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.